ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0915

Clinical Bedside Tools to Assess Systemic Sclerosis Vasculopathy: Can Digital Thermal Monitoring and Sublingual Microscopy Identify Patients with Current or past Digital Ulcers?

Tracy Frech1, Zhining Ou2, Julie Thomas2 and Angela Presson2, 1University of Utah and Salt Lake Veterans Affair Medical Center, Salt Lake City, UT, 2University of Utah, Salt Lake City, UT

Meeting: ACR Convergence 2020

Keywords: Scleroderma, Ulcers

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Systemic Sclerosis & Related Disorders – Clinical Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Sublingual microscopy is reported as a useful tool for vasculopathy assessment in SSc.  Digital thermal monitoring (DTM) correlates with flow-mediated dilatation, and may identify patients at risk for digital ulcer (DU). The purpose of this analysis was to assess sublingual microscopy and DTM in SSc patients with and without digital ulcers in order to determine the utility of these clinical tools for end-stage vasculopathy assessment.

Methods: Consented SSc registry patients that presented for routine clinical care and had both DTM and sublingual microscopy on the same day were included in this cross-sectional analysis. Measurements were performed in a quiet room at a controlled ambient temperature. DTM records a temperature rebound in the fingertip after blood pressure cuff occlusion, and is provided as a single, automated vascular reactivity index (VRI) value. Sublingual microscopy provides an automated measure of microvascular perfusion (longitudinal red blood cell fraction, RBC fract) and glycocalyx penetrability (perfused barrier region, PBR). We summarized demographics and clinical outcomes of interest using median, interquartile range (IQR) and range for skew continuous variables; we reported counts and percentages for categorical variables. Exact Wilcoxon rank sum test and Fisher’s exact test were used to compare variable between DU groups. We evaluated the pairwise association between VRI, RBCfract and PBR in a monotonic relationship using Spearman’s rank correlation in the DU subset. We reported the correlation coefficients (r-s) and their 95% confidence intervals (CIs). We also reported the asymptotic p-values. Statistical significance was assessed at the 0.05 level.

Results: Of the 90 patients that met inclusion criteria, 29 had digitals pits and/or active DU and 61 never had a DU (Table 1). These patients were 76% female, 83% white, 11% current smoker, and 87% SSc-specific autoantibody positive.  At the time of assessment, 91% were on vasodilators for Raynaud’s phenomenon. The only significant clinical feature associated with the presence of DU was modified Rodnan skin score (p=0.003).  The VRI captured by DTM was lower in patients with DU (p=0.01).  The sublingual microscopy RBCfract and PBR were monotonic associated (p < 0.001) with monotone decreasing with the higher RBCfract the lower PBR (r¬s=-0.71, 95% CI: -0.86, -0.47).  VRI was not associated with RBCfract or PBR (p=0.24 or 0.55, respectively) in the small group DU patients (Table 2).

Conclusion: DTM, which captures damage as a vasculopathy feature, is a potentially useful tool for assessing DU risk in the SSc population. In this cross-sectional analysis, sublingual microscopy measurements of perfusion and glycocalyx penetrability did not significantly correlate to VRI in DU patients’ assessment. However, a longitudinal study of these sublingual microscopy parameters may be more helpful in capturing vasculopathy activity prior to the possibly irreversible damage that is captured by DTM.

Clinical Features of 90 SSc patients assessed with Digital Thermal Monitoring and Sublingual Microscopy

Spearman’s rank correlation and 95% CI for 29 DU patients.


Disclosure: T. Frech, None; Z. Ou, None; J. Thomas, None; A. Presson, None.

To cite this abstract in AMA style:

Frech T, Ou Z, Thomas J, Presson A. Clinical Bedside Tools to Assess Systemic Sclerosis Vasculopathy: Can Digital Thermal Monitoring and Sublingual Microscopy Identify Patients with Current or past Digital Ulcers? [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/clinical-bedside-tools-to-assess-systemic-sclerosis-vasculopathy-can-digital-thermal-monitoring-and-sublingual-microscopy-identify-patients-with-current-or-past-digital-ulcers/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-bedside-tools-to-assess-systemic-sclerosis-vasculopathy-can-digital-thermal-monitoring-and-sublingual-microscopy-identify-patients-with-current-or-past-digital-ulcers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology